Literature DB >> 31576295

Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD.

Tammy L Sirich1,2, Glenn M Chertow2.   

Abstract

Entities:  

Year:  2019        PMID： 31576295      PMCID： PMC6685898          DOI： 10.21037/atm.2019.04.22

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  21 in total

1.  Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine.

Authors:  Mariska Davids; Albert J van Hell; Marlieke Visser; Robert J Nijveldt; Paul A M van Leeuwen; Tom Teerlink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-24       Impact factor: 4.733

2.  Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Authors:  Timothy W Meyer; Tammy L Sirich; Kara D Fong; Natalie S Plummer; Tariq Shafi; Seungyoung Hwang; Tanushree Banerjee; Yunnuo Zhu; Neil R Powe; Xin Hai; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

3.  Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin.

Authors:  Mustafa Erinc Sitar; Arslan Arinc Kayacelebi; Bibiana Beckmann; Jan T Kielstein; Dimitrios Tsikas
Journal:  Amino Acids       Date:  2015-04-29       Impact factor: 3.520

4.  Metabolite profiling identifies markers of uremia.

Authors:  Eugene P Rhee; Amanda Souza; Laurie Farrell; Martin R Pollak; Gregory D Lewis; David J R Steele; Ravi Thadhani; Clary B Clish; Anna Greka; Robert E Gerszten
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

Review 5.  Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.

Authors:  Nosratola D Vaziri; Ying-Yong Zhao; Madeleine V Pahl
Journal:  Nephrol Dial Transplant       Date:  2015-04-16       Impact factor: 5.992

Review 6.  Effects of nitric oxide on red blood cell development and phenotype.

Authors:  Vladan P Cokić; Alan N Schechter
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

Review 7.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

8.  Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

Authors:  Scott S Billecke; Louis G D'Alecy; Raylene Platel; Steven E Whitesall; Kenneth A Jamerson; Rachel L Perlman; Crystal A Gadegbeku
Journal:  Nephrol Dial Transplant       Date:  2008-09-15       Impact factor: 5.992

Review 9.  Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Toxins (Basel)       Date:  2017-03-06       Impact factor: 4.546

Review 10.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546
View more
  1 in total

1.  Medium cut-off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin-independent manner in maintenance hemodialysis patients: results from a randomized controlled trial.

Authors:  Jeong-Hoon Lim; Yena Jeon; Ju-Min Yook; Soon-Youn Choi; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim; Jang-Hee Cho
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.